Drug Designing and Targeting

Drug target is the naturally existing cellular structure involved in the pathology of interest that the drug-in-development is meant to act on. It is the process to discover a new drug and bringing a drug to the market once a lead compound has been identified.
Drug discovery and development is an intellectual solution which analyses scientific knowledge and data to reveal known, unknown and hidden connectivity that can help increase the vast possibilities of scientific development. It is used by pharmaceutical companies, medical device companies and academic institutions to assist with new drug target identification and drug re-purposing.

  • Computer-aided drug design
  • Structure-based Drug Design
  • Metabolic Half-Life
  • Bioavailability

Related Conference of Drug Designing and Targeting

January 29-30, 2026

19th World Drug Delivery Summit

Paris, France
February 10-11, 2026

40th World Congress on Pharmacology and Therapeutics

Barcelona, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
June 08-09, 2026

20th World Drug Delivery Summit

London, UK
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland

Drug Designing and Targeting Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in